Literature DB >> 29323639

The polio endgame: securing a world free of all polioviruses.

Michel Zaffran1, Michael McGovern2, Reza Hossaini3, Rebecca Martin4, Jay Wenger5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29323639     DOI： 10.1016/S0140-6736(17)32442-X

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

1.  Prevalence of poliovirus vaccine strains in randomized stool samples from 2010 to 2018: encompassing transition from the trivalent to bivalent oral poliovirus vaccine.

Authors:  Jira Chansaenroj; Watchaporn Chuchaona; Thanundorn Thanusuwannasak; Ausanee Duang-In; Jiratchaya Puenpa; Viboonsak Vutithanachot; Sompong Vongpunsawad; Yong Poovorawan
Journal:  Virusdisease       Date:  2019-03-21

Review 2.  Life-Threatening Infections Due to Live-Attenuated Vaccines: Early Manifestations of Inborn Errors of Immunity.

Authors:  Laura Pöyhönen; Jacinta Bustamante; Jean-Laurent Casanova; Emmanuelle Jouanguy; Qian Zhang
Journal:  J Clin Immunol       Date:  2019-05-23       Impact factor: 8.317

3.  Safety, Immunogenicity and Lot-to-Lot Consistency of Sabin-Strain Inactivated Poliovirus Vaccine in 2-Month-Old Infants: A Double-Blind, Randomized Phase III Trial.

Authors:  Yan Zheng; Zhifang Ying; Yanxiang Zou; Taotao Zhu; Dinggu Qian; Weixiao Han; Ya Jiang; Zhiwei Jiang; Xingyan Li; Jianfeng Wang; Jin Lei; Li Xu; Deyu Jiang; Changgui Li; Xiaoqiang Liu
Journal:  Vaccines (Basel)       Date:  2022-02-08

4.  Vaccine-Derived Poliovirus Infection among Patients with Primary Immunodeficiency and Effect of Patient Screening on Disease Outcomes, Iran.

Authors:  Mohammadreza Shaghaghi; Shohreh Shahmahmoodi; Ali Nili; Hassan Abolhassani; Seyedeh Panid Madani; Ahmad Nejati; Maryam Yousefi; Yaghoob M Kandelousi; Mona Irannejad; Shiva Shaghaghi; Seyed Mohsen Zahraei; Sussan Mahmoudi; Mohammad Mehdi Gouya; Reza Yazdani; Gholamreza Azizi; Nima Parvaneh; Asghar Aghamohammadi
Journal:  Emerg Infect Dis       Date:  2019-11       Impact factor: 6.883

5.  The experiences of using polio outbreak simulation exercises to strengthen national outbreaks preparedness and response plans in sub-Saharan Africa.

Authors:  Daudi Manyanga; Brine Masvikeni; Fussum Daniel
Journal:  Pan Afr Med J       Date:  2020-08-25

6.  Safety and immunogenicity of a new Sabin inactivated poliovirus vaccine candidate produced on the PER.C6® cell-line: a phase 1 randomized controlled trial in adults.

Authors:  Isabel Leroux-Roels; Geert Leroux-Roels; Georgi Shukarev; Hanneke Schuitemaker; Conor Cahill; Richard de Rooij; Martin Struijs; Hester van Zeeburg; Jeanne-Marie Jacquet
Journal:  Hum Vaccin Immunother       Date:  2020-11-11       Impact factor: 3.452

7.  Safety and Immunogenicity of a New Inactivated Polio Vaccine Made From Sabin Strains: A Randomized, Double-Blind, Active-Controlled, Phase 2/3 Seamless Study.

Authors:  Maria Rosario Capeding; Grace Devota Gomez-Go; Peninnah Oberdorfer; Charissa Borja-Tabora; Lulu Bravo; Josefina Carlos; Auchara Tangsathapornpong; Rattapon Uppala; Kamolwish Laoprasopwattana; Yunjeong Yang; Song Han; Orasri Wittawatmongkol
Journal:  J Infect Dis       Date:  2022-08-24       Impact factor: 7.759
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.